Evaluating the Pink and Pearl Campaign for Lung Cancer Screening
Official title: Evaluating the Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
Run by Washington University School of Medicine · NCT06898333 · Data updated 2026-11-12
This study is testing if the Pink and Pearl Campaign can encourage women aged 50-80 getting mammograms to also get screened for lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 279 (estimated) |
| Sponsor | Washington University School of Medicine Academic / other |
| Locations | 1 site (Creve Coeur, Missouri) |
| Status | Recruiting |
| Started | May 8, 2025 |
| Main results expected | November 30, 2026 |
| Study ends | May 31, 2027 |
| Registry record updated | August 12, 2026 |
| Trial ID | NCT06898333 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are women aged 50-80 with a significant smoking history who are currently undergoing screening mammography.
✕Probably not a fit
Patients with a serious health problem that limits life expectancy or those who have been diagnosed with lung cancer will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to assess the effectiveness of the Pink and Pearl Campaign in promoting lung cancer screening among women aged 50-80 who are undergoing mammography at BJC West County. It utilizes a mixed methods approach, combining quantitative and qualitative data to evaluate the prevalence of lung cancer screening and the impact of the campaign on referrals and completion rates. The study also examines individual and environmental factors that influence screening behavior, grounded in the Integrated Screening Action Model.
Why it matters
Potential benefit: If successful, this study could significantly increase lung cancer screening rates among eligible women, leading to earlier detection and improved outcomes.
How similar studies have gone: Other studies have shown success in using targeted campaigns to improve cancer screening rates, suggesting that this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Participants: * Undergoing screening mammography * Between the ages of 50-80 years (inclusive) * Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years * Can speak and understand English * Ability to understand willingness to provide informed consent. Exclusion Criteria for Participants: * Diagnosed with a serious health problem that will likely limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year) * Subjects with symptoms of lung cancer should get a diagnostic CT scan * Unable or unwilling to get treatment if lung cancer is found Eligibility Criteria for Providers: * Older than 20 years of age
Where it's running
-
Barnes-Jewish Hospital West County
Creve Coeur, Missouri, United States Recruiting
Study contacts
- Principal investigator: Beryne Odeny, M.D., MPH, Ph.D. — Washington University School of Medicine
- Study coordinator: Beryne Odeny, M.D., MPH, Ph.D.
- Email: beryne@wustl.edu
- Phone: 314-362-1183
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pink and Pearl campaign to link mammography visits with lung cancer screening at Christian Hospital.
This program will try to increase lung cancer screening among women aged 50–80 who come for mammograms at Christian Hospital.
-
Innovative care program for lung cancer survivors
This study is testing a new care program designed to help lung cancer survivors in Kentucky feel better and improve their quality of life compared to standard care.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.